GB0913345D0 - New combination 802 - Google Patents

New combination 802

Info

Publication number
GB0913345D0
GB0913345D0 GB0913345A GB0913345A GB0913345D0 GB 0913345 D0 GB0913345 D0 GB 0913345D0 GB 0913345 A GB0913345 A GB 0913345A GB 0913345 A GB0913345 A GB 0913345A GB 0913345 D0 GB0913345 D0 GB 0913345D0
Authority
GB
United Kingdom
Prior art keywords
new combination
new
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0913345A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
AstraZeneca AB
Original Assignee
Argenta Discovery Ltd
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd, AstraZeneca AB filed Critical Argenta Discovery Ltd
Priority to GB0913345A priority Critical patent/GB0913345D0/en
Publication of GB0913345D0 publication Critical patent/GB0913345D0/en
Application status is Ceased legal-status Critical

Links

GB0913345A 2009-07-31 2009-07-31 New combination 802 Ceased GB0913345D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0913345A GB0913345D0 (en) 2009-07-31 2009-07-31 New combination 802

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0913345A GB0913345D0 (en) 2009-07-31 2009-07-31 New combination 802
PCT/GB2010/051243 WO2011012897A1 (en) 2009-07-31 2010-07-29 New combinations for the treatment of asthma

Publications (1)

Publication Number Publication Date
GB0913345D0 true GB0913345D0 (en) 2009-09-16

Family

ID=41129408

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0913345A Ceased GB0913345D0 (en) 2009-07-31 2009-07-31 New combination 802

Country Status (2)

Country Link
GB (1) GB0913345D0 (en)
WO (1) WO2011012897A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009098448A1 (en) 2008-02-06 2009-08-13 Astrazeneca Ab Compounds
EP2386555A1 (en) 2010-05-13 2011-11-16 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
ITRM20110083U1 (en) 2010-05-13 2011-11-14 De La Cruz Jose Antonio Freire Plate for the construction of trucks for airplanes
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
EP2592078A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
BR112015013628A2 (en) 2012-12-18 2017-07-11 Almirall Sa carbamate derivatives cyclo-hexyl and quinuclidinila having adrenergic agonist activity and muscarinic antagonist beta2 m3
TWI643853B (en) 2013-02-27 2018-12-11 阿爾米雷爾有限公司 Having both β2 adrenergic receptor agonist and 2- M3 muscarinic receptor antagonist activity of the amino-l-hydroxyethyl-8-quinolin -2 (1H) - one derivatives of salts of
CN103141490B (en) * 2013-03-06 2015-09-16 浙江省亚热带作物研究所 (2-hydroxyethyl) adenosine N6- applied in the preparation of pesticidal crop reagent
TWI641373B (en) 2013-07-25 2018-11-21 阿爾米雷爾有限公司 Having muscarinic receptor antagonist and β2 adrenergic agonist activity of both receptors agent 2-amino-1-hydroxyethyl-8-quinolin -2 (1H) - one derivatives of salts of
TW201617343A (en) 2014-09-26 2016-05-16 Almirall Sa New bicyclic derivatives having [beta]2 adrenergic agonist and M3 muscarinic antagonist activities
WO2018059537A1 (en) * 2016-09-30 2018-04-05 四川海思科制药有限公司 Diazaspiro[5.5]undecane derivative and use thereof

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1390255A (en) 1999-11-24 2003-01-08 武田药品工业株式会社 Use of disease-associated gene
MXPA02006163A (en) 1999-12-24 2002-12-05 Hoffmann La Roche Nitrile derivatives as cathepsin k inhibitors.
GB0003154D0 (en) 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
CO5300399A1 (en) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs containing nitrogen, process for their preparation and pharmaceutical compositions containing them
AR028948A1 (en) 2000-06-20 2003-05-28 Astrazeneca Ab novel compounds
DK1309591T3 (en) 2000-08-14 2007-03-26 Ortho Mcneil Pharm Inc substituted pyrazoles
SE0100902D0 (en) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0102617D0 (en) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0102616D0 (en) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0104251D0 (en) 2001-12-14 2001-12-14 Astrazeneca Ab Novel compounds
SE0104331D0 (en) 2001-12-19 2001-12-19 Astrazeneca Ab Novel compounds
MY156407A (en) 2002-02-28 2016-02-26 Novartis Ag 5-phenylthiazole derivatives and use as p13 kinase inhibitors
AR039385A1 (en) 2002-04-19 2005-02-16 Astrazeneca Ab Thioxanthine derivatives as inhibitors of myeloperoxidase
SE0300091D0 (en) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300092D0 (en) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0301010D0 (en) 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SE0301569D0 (en) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
WO2004113286A2 (en) 2003-06-19 2004-12-29 Genaera Corporation Mucin synthesis inhibitors
EP1644326B1 (en) 2003-06-30 2016-11-02 Merck Canada Inc. Cathepsin cysteine protease inhibitors
SE0301963D0 (en) 2003-07-02 2003-07-02 Astrazeneca Ab New compounds
SA2304B1 (en) 2003-08-21 2009-11-10 استرازينيكا ايه بي Substiuted phenoxacetic as pharmaceutced compunds for treating respiratory diseases such as asthma and copd
SE0302486D0 (en) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
GB0324790D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Amide derivatives
CA2545660C (en) 2003-11-19 2013-06-04 Array Biopharma Inc. Heterocyclic inhibitors of mek and methods of use thereof
US20080255162A1 (en) 2004-05-04 2008-10-16 Warner-Lambert Company Llc Pyrrolyl Substituted Pyrido[2,3-D]Pyrimidin-7-Ones and Derivatives Thereof as Therapeutic Agents
SE0401762D0 (en) 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
AU2005318292B2 (en) 2004-12-23 2011-09-22 Galderma Research & Development Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics
WO2006091112A1 (en) 2005-02-22 2006-08-31 Genesis Reasearch And Development Corporation Limited Compositions for the delivery of rna interference molecules and methods for their use
US20070049591A1 (en) 2005-08-25 2007-03-01 Kalypsys, Inc. Inhibitors of MAPK/Erk Kinase
TW200738659A (en) 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
JP2009523769A (en) 2006-01-23 2009-06-25 ラボラトワール セローノ ソシエテ アノニム Thiazole derivatives and use of these
TW200745084A (en) * 2006-03-08 2007-12-16 Astrazeneca Ab Novel compounds
TW200806667A (en) 2006-04-13 2008-02-01 Astrazeneca Ab New compounds
WO2007123939A2 (en) 2006-04-19 2007-11-01 Laboratoires Serono S.A. Novel arylamino n-heteraryls as mek inhibitors
TW200808771A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
WO2007144198A2 (en) 2006-06-16 2007-12-21 Umc Utrecht Holding B.V. Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases
JP2009543860A (en) 2006-07-19 2009-12-10 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag New tricyclic spiropiperidine compounds, their use as their synthesis and chemokine receptor activity modulator
EP2059239A4 (en) 2006-09-07 2010-07-07 Parion Sciences Inc Enhanced mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
WO2008064136A2 (en) 2006-11-17 2008-05-29 Acadia Pharmaceuticals Inc. Compounds with activity at retinoic acid receptors
SE530201C2 (en) 2006-12-18 2008-03-25 Nilar Int Ab Collision detecting circuit breaker system for battery stack in electric or hybrid vehicle, releases pressure applied to bipolar battery stack by strut in event of collision
SA2628B1 (en) 2007-01-11 2011-04-24 استرازينيكا ايه بي Pyridopyrimidine Derivatives as PDE4 Inhibitors
GB0703999D0 (en) * 2007-03-01 2007-04-11 Astrazeneca Ab New combination 667
KR101541203B1 (en) 2007-06-27 2015-07-31 아스트라제네카 아베 Pyrazinone derivatives and their use in the treatment of lung diseases
WO2009037503A2 (en) * 2007-09-18 2009-03-26 Astrazeneca Ab New combination - 012 for the treatment of respiratory diseases
MX2010003698A (en) 2007-10-04 2010-04-21 Astrazeneca Ab Steroidal [3, 2-c] pyrazole compounds, with glucocorticoid activity.
WO2009098448A1 (en) * 2008-02-06 2009-08-13 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
WO2011012897A1 (en) 2011-02-03

Similar Documents

Publication Publication Date Title
GB0910545D0 (en) Picturesafe
GB0919432D0 (en) Use
HK1168791A1 (en) Substituted imidazoquinoxalines
EP2462514A4 (en) Greenbooks
ZA201202612B (en) Combination
GB0902393D0 (en) Elaectric machine - modular
EP2515891A4 (en) 3-keto-n-propargyl-1-aminoindan
ZA201108962B (en) Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
GB201003863D0 (en) Spectropotometer
GB0905568D0 (en) Taxling
HK1163005A1 (en) Tricyanoborates
GB0913345D0 (en) New combination 802
HK1174617A1 (en) Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts -1----2---
GB0904835D0 (en) Trailersafe
GB0913342D0 (en) Compounds - 801
GB0915552D0 (en) Cable-routing
ZA201202416B (en) Combination
GB0920535D0 (en) Tidysqueeze
ZA201108565B (en) Substituted piperidnes
EP2519921A4 (en) Call-tracking
GB0900404D0 (en) New compounds 4
GB0907834D0 (en) Easy-over
GB0912718D0 (en) Heliocycle
EP2448583A4 (en) Substituted 4-hydroxypyrimidine-5-carboxamides
EP2456311A4 (en) Substituted imidazotriazines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)